ad image

New Capabilities

1 / 1
On the Journey to Support Drug Developers With End-to-End Outsourcing
Expanded CDMO Capabilities

On the Journey to Support Drug Developers With End-to-End Outsourcing

Michelle Hall

Mikart

PAO-06-23-CL-04Jul 17, 2023
Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future
Microbiome Therapeutic Innovation

Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future

Stacy Burns-Guydish, Ph.D.; Gary Henderson

List Labs

PAO-03-23-CL-08Apr 04, 2023
Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing
Microbiome-Based CDMO

Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing

Stacy Burns-Guydish, Ph.D.; Jonathan Yongwan Jo; Gary Henderson; Michael Kimble

List Labs

PAO-11-022-CL-13Dec 13, 2022
AGC Biologics
New Facility

AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus

AGC Biologics

PR-M05-22-13-359May 18, 2022
Leveraging Existing Technologies with New Dedicated Facilities for mRNA Projects
mRNA

Leveraging Existing Technologies with New Dedicated Facilities for mRNA Projects

Scott Doncaster; Marc Sauer, Ph.D.

BIOVECTRA

PAO-02-022-CL-07Mar 12, 2022
Discovery Life Sciences
New Capabilities

Discovery Life Sciences Streamlines Cell and Gene Therapy Manufacturing with Expanded Human Cellular Starting Materials

Discovery Life Sciences

PR-M02-22-15Feb 17, 2022
1 / 1